CLINICAL_TRIALS
trial_result
· 2015-06-01
Clinical Trial Update: The Feasibility of Florbetapir Quantitation [Phase 4]
Summary
A Phase 4 trial update assessing the feasibility of quantifying florbetapir for PET imaging in Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimers Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-06-01